Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy

Hydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure prophylaxis it may prevent COVID-19. To compare the incidence of COVID-19 in Spanish patients with autoimmune rheumatic diseases treated with and wi...

Full description

Saved in:

Bibliographic Details
Published in:	PloS one Vol. 16; no. 4; p. e0249036
Main Authors:	Macías, Juan, González-Moreno, Paz, Sánchez-García, Esther, Morillo-Verdugo, Ramón, Pérez-Venegas, José J, Pinilla, Ana, Macho, MªMar, Martínez, MªVictoria, González-Serna, Alejandro, Corma, Anaïs, Real, Luis M, Pineda, Juan A
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 08-04-2021 Public Library of Science (PLoS)
Subjects:	Aged Biology and life sciences Clinical trials Complications and side effects Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control Cross-Sectional Studies Disease transmission Electronic health records Epidemics Ethics Exposure Female Health services Hospitals Humans Hydroxychloroquine Hydroxychloroquine - administration & dosage Incidence Infectious diseases Inflammatory diseases Internal medicine Male Medical records Medicine and Health Sciences Microbiology Middle Aged Pandemics Patients Pharmacy Physiological aspects Post-Exposure Prophylaxis Pre-Exposure Prophylaxis Prevention Prophylaxis Public health Retrospective Studies Rheumatic diseases Rheumatic Diseases - drug therapy Rheumatic Diseases - epidemiology Rheumatology Risk Factors SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Spain Spain - epidemiology Testing Therapy Viral diseases Spain
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!